Doctor profile · Federal record
Dr. Jesleen Ahluwalia, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1982816302
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1619 3Rd Ave, 29F
New York, NY 101283459
(617) 596-8897
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- April 16, 2013
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #264825
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982816302. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,153
Distinct HCPCS
10
Medicare allowed
$341,222
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,619 | 277 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 900 | 608 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 571 | 375 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 353 | 262 | $90 | |
17110 |
Destruction of skin growth, 1-14 growths | 306 | 231 | $106 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 278 | 203 | $125 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 274 | 13 | $111 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 166 | 166 | $111 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 106 | 20 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 91 | 61 | $49 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$1,880
Transactions
76
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 13 | $282.42 | |
| GENZYME CORPORATION | 9 | $266.72 | |
| Amgen Inc. | 4 | $204.90 | |
| PFIZER INC. | 10 | $188.97 | |
| Lilly USA, LLC | 9 | $178.93 | |
| Galderma Laboratories, L.P. | 12 | $169.08 | |
| Janssen Biotech, Inc. | 3 | $103.81 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $79.99 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $68.41 | |
| Novartis Pharmaceuticals Corporation | 3 | $63.70 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $62.48 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $39.09 | |
| Incyte Corporation | 2 | $37.73 | |
| Dermavant Sciences, Inc. | 2 | $37.10 | |
| Verrica Pharmaceuticals Inc. | 1 | $24.91 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
297
Patients
171
Total drug cost
$49,722
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 133 | 92 | $2,039 |
| Ketoconazole | Generic | 53 | 27 | $1,017 |
| Fluocinonide | Generic | 28 | 14 | $1,102 |
| Doxycycline Hyclate | Generic | 24 | 16 | $781 |
| Fluorouracil | Generic | 22 | 22 | $1,602 |
| Clobetasol Propionate | Generic | 13 | 0 | $751 |
| Dupixent Syringe (Dupilumab) | Brand | 12 | 0 | $42,366 |
| Hydrocortisone | Generic | 12 | 0 | $64 |
Frequently asked questions
What is Dr. Jesleen Ahluwalia's medical specialty?
Dr. Jesleen Ahluwalia practices Dermatology Physician in New York, NY.
Where does Dr. Jesleen Ahluwalia practice?
Dr. Jesleen Ahluwalia practices at 1619 3Rd Ave, New York, NY 101283459. Office phone: 6175968897.
What is Dr. Jesleen Ahluwalia's NPI?
Dr. Jesleen Ahluwalia's National Provider Identifier (NPI) is 1982816302, issued by NPPES.
Does Dr. Jesleen Ahluwalia accept Medicare assignment?
Yes. Dr. Jesleen Ahluwalia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jesleen Ahluwalia commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.